1-4 of 4
Julie M Fortier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma

Michael J Slade, Abir Khalid, Mark A Fiala, Mariya Liyasova, Mark A Zaydman, Zac McDonald, Julie M Fortier, Sarah Kelley, Zachary D. Crees, Mark A. Schroeder, Keith E Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood
Blood (2022) 140 (Supplement 1): 4376–4377.
https://doi.org/10.1182/blood-2022-155582
Published: 2022
Journal Articles

A Novel Serum Free Light Chain Metric Provides Greater Diagnostic Specificity and Robustness to Variation in Renal Function

Vahid Azimi, Michael J Slade, Mark A Fiala, Julie M Fortier, Keith E Stockerl-Goldstein, John L Frater, Jonathan R Brestoff, Ronald Jackups, Jr., Mark A Zaydman
Journal: Blood
Blood (2022) 140 (Supplement 1): 7160–7161.
https://doi.org/10.1182/blood-2022-167588
Published: 2022
Journal Articles

Association between Bone Marrow Immune Microenvironment Following Autologous Stem Cell Transplant and Duration of Response for Multiple Myeloma

Tianjiao Wang, Mark A Fiala, Julie M Fortier, Ruiyang Liu, Reyka G. Jayasinghe, Ravi Vij, Li Ding
Journal: Blood
Blood (2022) 140 (Supplement 1): 7066–7067.
https://doi.org/10.1182/blood-2022-169716
Published: 2022
Journal Articles

POU4F1 Is Associated with t(8;21) AML and Contributes Directly to Its Unique Transcriptional Signature.

Julie M. Fortier, PhD, Jacqueline E. Payton, MD, PhD, Patrick Cahan, Timothy J. Ley, MD, Matthew J. Walter, MD, Timothy A. Graubert, MD
Journal: Blood
Blood (2009) 114 (22): 2623.
https://doi.org/10.1182/blood.V114.22.2623.2623
Published: 2009